To generate successful gene therapies that are capable of delivering nucleic acids to specific cells and tissues, scientists must carefully design their products. They can employ either recombinant ...

Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent ...

In recent years, there has been much debate about the role of traditional therapy in psychedelic-assisted therapy. Some argue that the medicines are the primary agents of change, needing only minimal ...

At the heart of D&D lies the power of imagination. The Dungeon Master (DM), who plays the roles of all non-player characters (NPCs) and monsters, sets the stage for various scenes and acts to open up ...

Genmab said it would pay a premium of around 41% on Merus’s closing price on Friday for a deal giving it access to late-stage breakthrough petosemtamab.

Sept 10 (Reuters) - BridgeBio Pharma (BBIO.O), opens new tab said on Tuesday it will stop development of its experimental therapy for a genetic disease that affects the adrenaline-producing gland. The ...

Aug 14 (Reuters) - Schrödinger (SDGR.O), opens new tab said on Thursday it has stopped the development of an experimental drug after the death of two patients with a type of blood cancer in an ...

Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes Approval based on the TN-10 study, demonstrating Tzield’s ability to delay the ...

After Danielle Hicks introduces the panelists, Nisha Mohindra, MD, and Christopher Towe, MD, provide an overview of what an early-stage non-small cell lung cancer diagnosis means and how it is ...